Merck bags EU nod for infant RSV protection in major public health milestone
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Move strengthens footprint in Western India and expands multi-specialty care network
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
The company allocated €56 million to research and development for next-generation line solutions
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Subscribe To Our Newsletter & Stay Updated